In last trading session, Aura Biosciences Inc (NASDAQ:AURA) saw 1.23 million shares changing hands with its beta currently measuring 0.38. Company’s recent per share price level of $11.74 trading at $1.45 or 14.09% at ring of the bell on the day assigns it a market valuation of $582.42M. That closing price of AURA’s stock is at a discount of -5.2% from its 52-week high price of $12.35 and is indicating a premium of 48.98% from its 52-week low price of $5.99. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.12 million shares which gives us an average trading volume of 156.69K if we extend that period to 3-months.

For Aura Biosciences Inc (AURA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.44 in the current quarter.

Aura Biosciences Inc (NASDAQ:AURA) trade information

Upright in the green during last session for gaining 14.09%, in the last five days AURA remained trading in the green while hitting it’s week-highest on Friday, 10/18/24 when the stock touched $11.74 price level, adding 5.17% to its value on the day. Aura Biosciences Inc’s shares saw a change of 32.51% in year-to-date performance and have moved 29.30% in past 5-day. Aura Biosciences Inc (NASDAQ:AURA) showed a performance of 21.16% in past 30-days. Number of shares sold short was 1.15 million shares which calculate 6.95 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 23.5 to the stock, which implies a rise of 50.04% to its current value. Analysts have been projecting 22 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would drop -87.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -87.39% for stock’s current value.

Aura Biosciences Inc (AURA) estimates and forecasts

Statistics highlight that Aura Biosciences Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 63.28% of value to its shares in past 6 months, showing an annual growth rate of 11.92% while that of industry is 17.20. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -16.85% during past 5 years.

Aura Biosciences Inc (NASDAQ:AURA)’s Major holders

Insiders are in possession of 5.08% of company’s total shares while institution are holding 79.94 percent of that, with stock having share float percentage of 84.22%. Investors also watch the number of corporate investors in a company very closely, which is 79.94% institutions for Aura Biosciences Inc that are currently holding shares of the company. MATRIX CAPITAL MANAGEMENT COMPANY, LP is the top institutional holder at AURA for having 6.92 million shares of worth $52.34 million. And as of 2024-06-30, it was holding 13.9992 of the company’s outstanding shares.

The second largest institutional holder is EVENTIDE ASSET MANAGEMENT, LLC, which was holding about 5.8 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.734 of outstanding shares, having a total worth of $43.87 million.